| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |